Logo image of ALMDT.PA

MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALMDT - FR0011049824 - Common Stock

4.1 EUR
-0.08 (-2.03%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

2

ALMDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. Both the profitability and financial health of ALMDT have multiple concerns. While showing a medium growth rate, ALMDT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALMDT has reported negative net income.
ALMDT had a negative operating cash flow in the past year.
ALMDT had negative earnings in each of the past 5 years.
ALMDT had a negative operating cash flow in each of the past 5 years.
ALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of ALMDT (-113.84%) is worse than 90.00% of its industry peers.
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROIC N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMDT.PA Yearly ROA, ROE, ROICALMDT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

ALMDT's Gross Margin of 102.73% is amongst the best of the industry. ALMDT outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALMDT has remained more or less at the same level.
ALMDT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 102.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
ALMDT.PA Yearly Profit, Operating, Gross MarginsALMDT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

0

2. Health

2.1 Basic Checks

ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMDT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMDT has been increased compared to 5 years ago.
Compared to 1 year ago, ALMDT has a worse debt to assets ratio.
ALMDT.PA Yearly Shares OutstandingALMDT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALMDT.PA Yearly Total Debt VS Total AssetsALMDT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -12.21, we must say that ALMDT is in the distress zone and has some risk of bankruptcy.
ALMDT's Altman-Z score of -12.21 is on the low side compared to the rest of the industry. ALMDT is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.21
ROIC/WACCN/A
WACC7.49%
ALMDT.PA Yearly LT Debt VS Equity VS FCFALMDT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
With a Current ratio value of 0.35, ALMDT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, ALMDT is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
ALMDT.PA Yearly Current Assets VS Current LiabilitesALMDT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

ALMDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.99%, which is quite good.
The Revenue has been growing slightly by 6.75% in the past year.
Measured over the past years, ALMDT shows a very strong growth in Revenue. The Revenue has been growing by 20.72% on average per year.
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%

3.2 Future

ALMDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.15% yearly.
The Revenue is expected to grow by 22.71% on average over the next years. This is a very strong growth
EPS Next Y46.62%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALMDT.PA Yearly Revenue VS EstimatesALMDT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALMDT.PA Yearly EPS VS EstimatesALMDT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMDT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMDT.PA Price Earnings VS Forward Price EarningsALMDT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMDT.PA Per share dataALMDT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ALMDT's earnings are expected to grow with 26.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.92%
EPS Next 3Y26.15%

0

5. Dividend

5.1 Amount

No dividends for ALMDT!.
Industry RankSector Rank
Dividend Yield 0%

MEDIAN TECHNOLOGIES

EPA:ALMDT (1/12/2026, 7:00:00 PM)

4.1

-0.08 (-2.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-23 2025-10-23
Earnings (Next)04-27 2026-04-27/amc
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap150.55M
Revenue(TTM)23.31M
Net Income(TTM)-22.21M
Analysts85.45
Price Target8.81 (114.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-78.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.63
BVpS-1.1
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 102.73%
FCFM N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
F-Score2
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.46%
Cap/Sales 3.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -12.21
F-Score2
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)102.16%
Cap/Depr(5y)84.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y46.62%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y26.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.89%
EBIT Next 3Y24.38%
EBIT Next 5YN/A
FCF growth 1Y23.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.85%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIAN TECHNOLOGIES / ALMDT.PA FAQ

What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.


What is the valuation status for ALMDT stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.


What is the profitability of ALMDT stock?

MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.


How financially healthy is MEDIAN TECHNOLOGIES?

The financial health rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10.